iShares NASDAQ Biotechnology I… (NASDAQ:IBB)

Tuesday’s Top BioPharma Movers Deviating from the Market

Tuesday was a breakout day for a few biotech companies, and that was the case even before news broke that the U.S. and China would be meeting at the G20 ...
Read Full Story »

The Best Biotech ETFs to Buy Ahead of ASCO

The 55th annual meeting of the American Society of Clinical Oncology (ASCO) is just around the corner. Biotech and pharmaceutical companies will descend on Chicago for a five-day all-out conference ...
Read Full Story »

The Top 10 Biotechs of 2019

Markets are soaring, and 2019 has been a big win so far for most investors playing the game. However not all sectors are keeping pace, and some are very imbalanced. ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

How Wall Street Is Looking at Q3 Earnings Season, Sector by Sector

The week of October 15 to October 19 is when third-quarter earnings will fly into hyper-drive. Endless numbers of America's biggest and smallest companies communicating the most recent quarter and ...
Read Full Story »

Merrill Lynch Sees 4 Top Biotechs With Key Catalysts in 2018

Biotechnology companies offer big risk, but big reward as well. These are seen as some of the more speculative companies in the market because a single clinical trial could either ...
Read Full Story »

6 Speculative Biotech Stocks With 50% to 250% Potential Upside

It's no secret that one of the strongest raging bull markets of our lifetime is taking place. At the start of 2018, the bull market was almost nine years old. Many ...
Read Full Story »

Meet Merrill Lynch’s Top Biotech Picks for 2018

While 2017 was a strong year for the markets — especially technology stocks — biotech and health care stocks in general were only able to keep pace. The iShares Nasdaq ...
Read Full Story »

Merrill Lynch’s Top 4 Internet Stocks for the Second Half of 2017

The technology sector has seen a big boom over the course of the past year, with the Technology Select Sector SPDR ETF (NYSEMKT: XLK) up over 25% in this time, ...
Read Full Story »

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has ...
Read Full Story »
Unhealthy Person

3 Sleeper Biotechs That Could Bounce Back Strong in 2017

When traders look at a stock at its highs and imagine what would be had they gotten in at the lows, the thought that invariably gets triggered is “At the ...
Read Full Story »
white pills

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

After Time named President-Elect Donald Trump Person of the Year, calling him President of the Divided States of America, there was one more ebb and flow for the state of business ...
Read Full Story »
Carnival cruise ship

Why We Could Expect a Zika Rally in These Stocks

When we think of summer, we think of going to the beach or seeing the ocean and soaking up the sun, maybe even going on a cruise. However this summer ...
Read Full Story »
100 dollar bills

Capital Infusions Are More Evidence of a Biotech Turnaround

The collapse of biotech giant Valeant Pharmaceuticals International Inc. (NYSE: VRX) has accelerated and possibly prolonged the biotech decline, infecting the entire sector. While negative news from the company and ...
Read Full Story »
investing

3 Stocks With Catalysts That Could Capitalize on Biotech Momentum

Biotechnology is on the move. A familiar bull market pattern since 2008 may be about to reestablish itself. That is, the S&P 500 is moving higher, outpaced by the Nasdaq, ...
Read Full Story »